"Diverse" Indian market to touch $20 billion by 2015, says McKinsey
This article was originally published in Scrip
Executive Summary
India's domestic pharmaceutical market is poised to grow to $20 billion by 2015 from about $11.5 billion (at end-consumer price levels) in 2008-09, with almost 60% of this growth expected to be driven by shifts in income demographics and the rise in medical infrastructure, according to McKinsey & Company.